{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-002726","form_type":"8-K","ticker":"TBPH","cik":"0001583107","company_name":"Theravance Biopharma, Inc.","filed_at":"2026-01-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.533079+00:00","generated_at":"2026-05-16T10:52:09.175669+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Theravance Biopharma holds investor meetings with January 2026 corporate slide deck; no new financials or guidance","bullets":["Management team conducting one-on-one meetings with analysts and investors in San Francisco from Jan 12-15, 2026.","Slide deck furnished as Exhibit 99.1 contains corporate overview but no material new information beyond prior disclosures.","Filing under Regulation FD; no financial updates, pipeline changes, or guidance adjustments disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-002726","json":"https://secwatch.observer/filing/0001104659-26-002726.json","markdown":"https://secwatch.observer/filing/0001104659-26-002726.md","text":"https://secwatch.observer/filing/0001104659-26-002726.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1583107/000110465926002726/0001104659-26-002726-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1583107/000110465926002726/tm262807d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T10:52:09.175669+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}